Biohaven Analyst Ratings
BenzingaApr 23 23:39
UBS: Maintaining the Biohaven (BHVN.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $59.00 to $60.00.
Zhitong FinanceApr 23 23:40
Analysts Are Bullish on Top Healthcare Stocks: Biohaven Ltd. (BHVN), Becton Dickinson (BDX)
TipRanksApr 23 19:10
Biohaven Analyst Ratings
BenzingaApr 18 21:48
Buy Rating Affirmed for Biohaven Ltd. Amid Positive Clinical Outlook and Pipeline Potential
TipRanksApr 15 09:36
Analysts Offer Insights on Healthcare Companies: Biohaven Ltd. (BHVN), Zoetis (ZTS) and Ginkgo Bioworks Holdings (DNA)
TipRanksApr 15 09:40
Cantor Fitzgerald Corp.: Reiterates Biohaven's (BHVN.US) shareholding rating.
Zhitong FinanceApr 11 01:31
Biohaven Analyst Ratings
BenzingaApr 11 01:26
Royal Bank of Canada: Reiterates the Biohaven (BHVN.US) rating and adjusted from superior to superior market rating, with a target price of $61.00.
Zhitong FinanceApr 9 21:20
Biohaven Analyst Ratings
BenzingaApr 9 21:15
RBC Capital Reiterates Outperform on Biohaven, Maintains $61 Price Target
BenzingaApr 9 21:17
Analysts Offer Insights on Healthcare Companies: Structure Therapeutics, Inc. Sponsored ADR (GPCR), AstraZeneca (AZN) and Biohaven Ltd. (BHVN)
TipRanksMar 21 14:51
Biohaven Analyst Ratings
BenzingaMar 4 19:34
HC Wainwright & Co. Maintains Buy on Biohaven, Raises Price Target to $63
BenzingaMar 4 19:35
Buy Rating Affirmed: Biohaven Ltd. Poised for Key Milestones With Diverse Portfolio and Promising Lead Molecule BHV-7000
TipRanksMar 4 19:26
Buy Rating Affirmed for Biohaven Ltd. on Strong Pipeline and Upcoming Drug Advancements
TipRanksMar 4 10:25
TD Cowen Maintains Outperform on Biohaven, Raises Price Target to $55
BenzingaMar 1 21:39
Biohaven Analyst Ratings
BenzingaMar 1 21:37
Piper Sandler Remains a Buy on Biohaven Ltd. (BHVN)
TipRanksMar 1 20:47
RBC Trims Price Target on Biohaven to $61 From $62, Keeps Outperform, Speculative Risk
MT NewswiresMar 1 20:08
No Data
No Data